Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

ICU Medical (ICUI) and Otsuka are launching a joint venture focused on boosting IV solutions production and development in North America. Read more here.

The nation's depleted supply of IV solutions is recovering after a North Carolina facility recently resumed production after ...

YARMOUTH, Maine – A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy solutions, says Connie Sullivan of the National Home Infusion ...

Like hospitals around the country, North Country Hospital is navigating the shortage of IV solution supplies, caused by the ...

The medical supply manufacturer said initial batches will not be ready to ship until late November at the earliest.

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces its strategic expansion into the U.S. and Latin American markets to address critical shortages of IV fluids. Responding to ...